BioHealth News Archive
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene…
Read More
CBS19 – UVA to break ground on new biotechnology institute
ALBEMARLE COUNTY, Va. (CBS19 NEWS) -- State and local officials will be on hand for a groundbreaking ceremony at the University of Virginia on Friday.…
Read More
University of Maryland and BioGenCell Announce the Launch of BioGenCell Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
BALTIMORE, Dec. 7, 2023 /PRNewswire/ -- BioGenCell, a pioneer in personalized cell therapy solutions, is excited to announce the launch of its fifth Phase II clinical…
Read More
Washington’s Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has acquired U.S. and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals…
Read More
ARPA-H Selects Site for Stakeholder & Operations Hub
ARPA-H made its final hub location decision, selecting the historic Bowen Building in downtown Washington, D.C. as the site for its Stakeholder & Operations…
Read More
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today announced that the company has been named on Newsweek’s list…
Read More
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study
ROCKVILLE, M.D. and SUZHOU, China, Dec. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines…
Read More
ComputChem Launches State-of-the-Art Approach to Predicting pKa Values with New Product: iTitrate®
A powerful web app to help drug designers accurately predict the pKa value of titratable residues December 5, 2023, Baltimore, MD – ComputChem, an…
Read More
Danaher Completes Acquisition of Abcam
WASHINGTON, Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam…
Read More
Gaithersburg’s Altimmune open to partnerships, deals with drugmakers, says CEO
By Pratik Jain and Khushi Mandowara - Dec 5 (Reuters) - Weight-loss drug developer Altimmune (ALT.O) is open to deals and collaborations with large drugmakers as it actively looks for partners…
Read More
Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca in BioHealth Capital Region
Matan Companies, a leading real estate development and investment firm, announced today the successful execution of a full-building lease agreement with AstraZeneca, a global,…
Read More
Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO
Biotech entrepreneur, company founder, tireless patient advocate, and U.S. Navy combat veteran will guide the life science industry in its mission to feed, fuel…
Read More
CarrTech Corp. Poised to Reduce Needle Sticks & Glass Shard Contamination in Medications
Revolutionizing the way healthcare providers administer medicines from glass ampoules FREDERICK, Md., Dec. 4, 2023 /PRNewswire-PRWeb/ -- CarrTech Corp., a woman-owned startup and Qualified Maryland Biotechnology…
Read More
Get Pre-Application Support through the NHLBI Innovator to Entrepreneur Program!
The National Heart Lung and Blood Institute (NHLBI) in partnership with the National Institute of Allergy and Infectious Diseases (NIAID) will be providing training…
Read More
Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Sara M. Nayeem, M.D. has joined the…
Read More